---
title: "NHS National Generic Pharmaceuticals Transition 2021_2 - Pemetrexed Solution for Infusion - LSNE"
ocid: "ocds-h6vhtk-02a9fe"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a9fe"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02a9fe.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02a9fe.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)"
published: "2021-07-14"
---

# NHS National Generic Pharmaceuticals Transition 2021_2 - Pemetrexed Solution for Infusion - LSNE

Buyer: THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)  
Current stage: Award  
OCID: ocds-h6vhtk-02a9fe

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a9fe)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02a9fe.json)

## Summary

The NHS Commissioning Board, operating under the name NHS England, is conducting a public procurement process for the title "NHS National Generic Pharmaceuticals Transition 2021_2 - Pemetrexed Solution for Infusion - LSNE". This procurement is classified under the pharmaceutical products category, taking place within the UK. Currently, the procurement is in the Award stage, with a contract that has been signed and is active. The framework agreement has a total maximum duration of 38 months, initiated on 24th June 2021 and due to conclude on 31st January 2023. Interested suppliers must register on the specified eTendering portal by a relevant deadline for participation.

This tender presents significant opportunities for growth, especially for pharmaceutical companies that can provide solutions for health services. Businesses capable of navigating the NHS procurement process and equipped to meet the technical specifications will find this framework advantageous. With the possibility for multiple call-offs throughout the agreement period, suppliers who are agile and innovative in their offerings will particularly benefit in this highly competitive tender.

## Notice

NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed solution for infusion LSNE region.Offer reference number: CM/PHG/21/5639/00Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)FIND A TENDER (FTS) Reference number: 2021/S 000-008845Potential periods of call-offs under the framework agreement: 24/06/2021 to 31/01/2023 (19 months) LSNE region.

### Lot Information

Lot 1

NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed solution for infusion LSNE regionOffer reference number: CM/PHG/21/5639/00Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)Potential periods of call-offs under the framework agreement:24/06/2021 to 31/01/2023 (19 months) LSNE region. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/016442-2021 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 14 Jul 2021 |
| Submission deadline | 26 May 2021 |
| Future notice date | Not specified |
| Award date | 16 Jun 2021 |
| Contract period | 23 Jun 2021 - 31 Jan 2023 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £3,040 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND) |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | MYLAN |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 14 Jul 2021 at 08:26 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/016442-2021
- 26 Apr 2021 at 09:12 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/008845-2021

## Notice URLs

- http://health.atamis.co.uk
- http://health.atamis.co.ukCandidates
- https://supplierregistration.cabinetoffice.gov.ukand
- https://www.england.nhs.uk/
- https://www.gov.uk/courts-tribunals

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a9fe. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02a9fe.json.